Cargando…

Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways

Psoriasis is a chronic inflammatory skin disease that affects approximately 2% of worldwide population, and causing long-term troubles to the patients. Therefore, it is urgent to develop safe and effective therapeutic drugs. Catalpol is a natural iridoid glucoside, that has several remarkable pharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Aimin, Zhang, Buxin, Zhao, Wei, Tu, Yuanhui, Wang, Qingxing, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806253/ https://www.ncbi.nlm.nih.gov/pubmed/33323018 http://dx.doi.org/10.1080/21655979.2020.1863015

Ejemplares similares

Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway
por: Liu, Aimin, et al.
Publicado: (2020)

Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation
por: Xu, Fengli, et al.
Publicado: (2019)

Schisandra extract ameliorates arthritis pathogenesis by suppressing the NF‐κB and MAPK signalling pathways
por: Han, Seong Jae, et al.
Publicado: (2023)

Catalpol Alleviates Depression by Inhibiting NLRP3 Inflammasome via TLR4/MAPK/NF-Kb Pathway
por: Liang, Xuemei, et al.
Publicado: (2023)

Catalpol-mediated microRNA-34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer
por: Qiao, Peng-Fei, et al.
Publicado: (2020)

4'-O-β-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-κB and MAPK signaling pathways
por: Fu, Jing, et al.
Publicado: (2020)

Analyses of Transcriptomics upon IL-1β-Stimulated Mouse Chondrocytes and the Protective Effect of Catalpol through the NOD2/NF-κB/MAPK Signaling Pathway
por: Pang, Yong, et al.
Publicado: (2023)

Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways
por: Guo, Hengke, et al.
Publicado: (2022)

Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF-κB and MAPK signal pathways
por: Ran, Jisheng, et al.
Publicado: (2018)

Magnoflorine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Suppressing NF-κB and MAPK Activation
por: Guo, Shuai, et al.
Publicado: (2018)

Inhibiting USP14 ameliorates inflammatory responses in trophoblast cells by suppressing MAPK/NF‐κB signaling
por: Zhao, Yingzi, et al.
Publicado: (2021)

P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
por: Chen, Haiming, et al.
Publicado: (2022)

Magnoflorine Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response via the NF-κB/MAPK Signaling Pathways
por: Wang, Lei, et al.
Publicado: (2023)

Identification of PANoptosis-related biomarkers and immune infiltration characteristics in psoriasis
por: Lu, Lingling, et al.
Publicado: (2023)

Treatment with catalpol protects against cisplatin-induced renal injury through Nrf2 and NF-κB signaling pathways
por: Zhang, Jun, et al.
Publicado: (2020)

Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019)

Cordyceps cicadae Mycelia Ameliorate Cisplatin-Induced Acute Kidney Injury by Suppressing the TLR4/NF-κB/MAPK and Activating the HO-1/Nrf2 and Sirt-1/AMPK Pathways in Mice
por: Deng, Jeng-Shyan, et al.
Publicado: (2020)

Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
por: de Gregorio, Estefanía, et al.
Publicado: (2020)

Epac‐2 ameliorates spontaneous colitis in Il‐10 (−/−) mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling
por: Song, Xue, et al.
Publicado: (2021)

Neobavaisoflavone ameliorates LPS-induced RAW264.7 cell inflammations by suppressing the activation of NF-κB and MAPKs signaling pathways
por: Yuan, Qing, et al.
Publicado: (2022)

Ubiquitin-specific protease 8 ameliorates lipopolysaccharide-induced spleen injury via suppression of NF-κB and MAPK signaling pathways
por: Bi, Wei, et al.
Publicado: (2022)

Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
por: Lu, Jiansen, et al.
Publicado: (2021)

Catalpol Enhances Random-Pattern Skin Flap Survival by Activating SIRT1-Mediated Enhancement of Autophagy
por: Jiang, Ren-hao, et al.
Publicado: (2022)

Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation
por: Wang, Ya-lin, et al.
Publicado: (2021)

PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines
por: Dou, Rongkun, et al.
Publicado: (2017)

Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
por: Zhao, Baoxia, et al.
Publicado: (2022)

Correction to Epac‐2 ameliorates spontaneous colitis in Il‐10 (−/−) mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling
Publicado: (2023)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
por: Quan, Gui-Hua, et al.
Publicado: (2015)

Adiporedoxin suppresses endothelial activation via inhibiting MAPK and NF-κB signaling
por: He, Hui, et al.
Publicado: (2016)

Artemisia gmelinii Attenuates Lung Inflammation by Suppressing the NF-κB/MAPK Pathway
por: Kim, Seung Yong, et al.
Publicado: (2022)

Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis via Regulating the MAPK/NF-κB-Autophagy Pathway
por: Yao, Minjun, et al.
Publicado: (2022)

Corilagin ameliorates macrophages inflammation in atherosclerosis through TLR4-NFκB/MAPK pathway
por: Meng, Da, et al.
Publicado: (2023)

SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-κB pathway
por: Li, Guoqing, et al.
Publicado: (2018)

Correction: PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines
por: Dou, Rongkun, et al.
Publicado: (2018)

Mangiferin and Taurine Ameliorate MSRV Infection by Suppressing NF-κB Signaling
por: Dai, Caijiao, et al.
Publicado: (2023)

The Patatin–Like Phospholipase Domain Containing Protein 7 Regulates Macrophage Classical Activation through SIRT1/NF-κB and p38 MAPK Pathways
por: Zhao, Zheng, et al.
Publicado: (2022)

SIRT7 Regulates Lipopolysaccharide-Induced Inflammatory Injury by Suppressing the NF-κB Signaling Pathway
por: Chen, Kun-Lin, et al.
Publicado: (2019)

Role of catalpol in ameliorating the pathogenesis of experimental autoimmune encephalomyelitis by increasing the level of noradrenaline in the locus coeruleus
por: Li, Qian, et al.
Publicado: (2018)

Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway
por: Huang, Dan, et al.
Publicado: (2022)

Anti-Neuroinflammatory Effect of Alantolactone through the Suppression of the NF-κB and MAPK Signaling Pathways
por: Tan, Liwei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dls7ug52mghv2jlpa685dm46kc